Salisa Hauptmann
Vice President, Regulatory Affairs

Salisa Hauptmann is vice president, Regulatory Affairs for Stiefel, a GSK company. She has worked in the pharmaceutical industry for nearly 20 years.

Salisa began her career working in Quality Assurance in the areas of product release and internal/external auditing. Salisa later transitioned to Regulatory Affairs and has been responsible for more than ten New Drug Applications (NDA) and Biologics License Applications (BLA) filings, as well as numerous global registrations.

Salisa’s therapeutic background is very broad having worked at several global pharmaceutical companies in the areas of respiratory, neurology and oncology before her tenure began with Stiefel.

While at Stiefel, Salisa has led her Regulatory team to secure three NDA filings, and numerous cosmetic registrations and launches globally. She established a dermatology industry regulatory consortium, and has been very successful with establishing a solid rapport with the U.S. FDA Division of Dermatology and Dental Products (DDDP), as well as with other health authorities around the world.

Salisa has also been an active speaker with several industry groups including CBI (Center for Business Intelligence) and RAPS (Regulatory Affairs Professionals Society), and has authored several articles in industry magazines.

Salisa holds a bachelor’s degree from the University of California at Davis, and received her master’s degree in Public Health from Webster University.

«Back to Stiefel Leadership Team